Drug · DIN 02269201
AVONEX
PREFILLED SYRINGE AND PREFILLED AUTOINJECTOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 2, 2005; first marketed December 2, 2005.
- Drug Identification Number (DIN)
- 02269201
- Company (DIN owner)
- Biogen Canada IncToronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Interferon beta-1a L03AB07
- Class
- Human
- Record last updated
- August 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INTERFERON BETA-1A | 30 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 18, 2005: NOC 7244Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named AVONEX
- DIN 02237770 · Cancelled Post Market
- DIN 02267594 · Approved